Key Dates

Related Announcements

RFA-OD-20-020 - Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)

RFA-OD-20-021 - Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)

RFA-OD-20-016 - Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)

RFA-OD-20-023 - Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)

NOT-OD-20-159 - Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19)

NOT-OD-20-152 - Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool

NOT-OD-21-035 - Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad)

Issued by

NATIONAL INSTITUTES OF HEALTH (NIH)

Purpose

The purpose of this notice is to update the terms and conditions of award for recipients of grant awards issued under the RADx Radical (rad) initiative. This includes specifically all grants that were issued in response to the following Funding Opportunity Announcements (FOAs) and Notices of Special Interest (NOSIs).

• RFA-OD-20-020 Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)
• RFA-OD-20-021 Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)
• RFA-OD-20-016 Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)
• RFA-OD-20-023 Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)
• NOT-OD-20-159 Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19)
• NOT-OD-20-152 Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool
• NOT-OD-21-035 Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad)

This guide notice does not apply to cooperative agreement awards, or awards issued outside of these FOAs and NOSIs.

Interim Reports

In addition to the annual Research Performance Progress Report (RPPR), recipients of awards issued in response to the FOAs and NOSIs above are required to submit an interim progress report every six months outlining key milestones that have been met.

• Recipients must upload the interim report using the Additional Materials (AM) tool in eRA. The Authorized Organization Official is required to submit interim reports to the Grants Management Official named on the Notice of Award using AM.

• The interim progress report must outline the following:
  • For each specific aim, submit a brief summary of major activities, significant results, and key outcomes or other achievements.

• Interim reports for the first year of these grant awards are due on June 30, 2021

Annual Reports

Recipients will continue to report information on the competitive revision supplements in the annual RPPR, Section G.1, as directed by the current term of award, and must include updates to the information provided in the interim report (as outlined in the above bullets).

Inquiries

Please direct all inquiries to:

Please direct all grants policy inquiries to:

NIH Office of Policy for Extramural Research Administration

Division of Grants Policy

[email protected]

For questions regarding a specific grant award please contact the Grants Management Specialist identified in the Notice of Award.